GNTbm-38 2HCl

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameGNTbm-38 2HCl
Drug Alias NameGNTbm-38 2HCl
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLymphoma, T-Cell, Peripheral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai PPC Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai PPC Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, T-Cell, Peripheral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A